News
The NIH Technology Transfer Program was honored with its record 7th “Deal of Distinction Award” at the 2025 Licensing Executives Society Annual Meeting. This award was given to NIH and its licensee Bavarian Nordic for the deal that led to the new chikungunya virus vaccine Vimkunya ®. Vimkunya
Are you interested in learning more about technology transfer or taking a class with the Foundation for Advanced Education in the Sciences (FAES) at the NIH? Attend the Virtual Open House on Monday, March 2 for its online Spring 2021 Academic Programs, including the several courses for its “Advanced
The importance of seemingly obscure medical research is often hard for the general public to understand when they are looking into where federal funding goes. In the 70s and 80s, this led to federally funded scientific research often being singled out and awarded Senator Proxmire’s “Golden Fleece
On Wednesday, December 16th NCI is showcasing an exciting opportunity to license a technology that has the capability to improve efficacy of HIV vaccines. This method can be used to develop more efficacious vaccine compositions by activating Ras before, during, or after vaccination. Additionally